Hospital Acquired Disease Testing Market, Size is estimated to be US$ 14.91 billion by 2030

Nehashaikh23 May, 2022News

Global Hospital Acquired Disease Testing Market accounted for US$ 7.2 billion in 2020 and is estimated to be US$ 14.91 billion by 2030 and is anticipated to register a CAGR of 7.6%. Viral, bacterial, and fungal pathogens cause hospital-acquired infections (HIA). Nosocomial infection, also known as hospital acquired infection, is an illness that develops in a specific site, such as a hospital, due to the presence of toxins. During their hospital stays, patients with impaired immune systems are at a greater risk of contracting an infection. Healthcare workers, infected medical equipment, bed linens, and air droplets are all potential sources of infection. Infection can also come from the outside world, another infected patient, or employees infected with an unknown pathogen.